Talecris Biotherapeutics Holdings Corp. (V9SNS*IJ) is a publicly traded company in the Unknown sector. Across all available filings, 4 corporate insiders have executed 4 transactions totaling $10.9M, demonstrating a bearish sentiment with -$10.9M in net insider flow. The most recent transaction on Sep 3, 2010 involved a sale of 113,440 shares valued at $2.6M.
No significant insider buying has been recorded for V9SNS*IJ in the recent period.
No significant insider selling has been recorded for V9SNS*IJ in the recent period.
Based on recent SEC filings, insider sentiment for V9SNS*IJ is bearish with an Insider Alignment Score of 0/100 and a net flow of -$10.9M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Talecris Biotherapeutics Holdings Corp. (V9SNS*IJ) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 4 insiders are actively trading V9SNS*IJ stock, having executed 4 transactions in the past 90 days. The most active insider is John R. Perkins II (Executive), who has made 1 transactions totaling $5.3M.
Get notified when executives and directors at V9SNS*IJ file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Sep 3, 2010 | J. Lynch Thomas | Executive | Sale | 113,440 | $22.50 | $2.6M | Large |
| Sep 2, 2010 | R. Perkins John II | Executive | Sale | 237,937 | $22.30 | $5.3M | Large |
| Sep 1, 2010 | Nogales Bruce | Executive | Sale | 40,000 | $21.99 | $879.6K | Large |
| Aug 30, 2010 | L. Menichella Daniel | Executive | Sale | 100,000 | $22.05 | $2.2M | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 4 | $10.9M | 100.0% |
Insider selling pressure at Talecris Biotherapeutics Holdings Corp. has increased, with 4 insiders executing 4 transactions across all time. Total sales of $10.9M significantly outpace purchases of $0, resulting in a net outflow of $10.9M. This selling activity appears largely discretionary, which may warrant closer attention from investors.